Entospletinib Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
KRON | D | Kronos Bio, Inc. | 2.06 | |
AFMD | F | Affimed Therapeutics B.V. | 0.93 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Biology
Blastoma
CD19
Cancer
Cancer Therapeutics
Chronic Lymphocytic Leukemia
Clinical Development
Cyclin Dependent Kinase
Enzymes
Epidermal Growth Factor Receptor
Glioblastoma
Head And Neck Cancer
Hematologic Malignancies
Hodgkin Lymphoma
Immunotherapies
Lymphocytic Leukemia
Lymphoma
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | B | iShares Microcap ETF | 0.01 | |
VTI | B | Vanguard Total Stock Market ETF | 0.0 | |
VXF | A | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Biology
Blastoma
CD19
Cancer
Cancer Therapeutics
Chronic Lymphocytic Leukemia
Clinical Development
Cyclin Dependent Kinase
Enzymes
Epidermal Growth Factor Receptor
Glioblastoma
Head And Neck Cancer
Hematologic Malignancies
Hodgkin Lymphoma
Immunotherapies
Lymphocytic Leukemia
Lymphoma
- Entospletinib
Entospletinib is an experimental drug for the treatment of various types of cancer under development by Gilead Sciences. It is an inhibitor of spleen tyrosine kinase (Syk). It has entered clinical trials for acute myeloid leukaemia (AML), chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma (DLBCL), graft-versus-host disease (GvHD), hematological malignancies, mantle cell lymphoma (MCL), and non-Hodgkin lymphoma (NHL).
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles